Skip to main content
Premium Trial:

Request an Annual Quote

PathoFinder SARS-CoV-2 PCR Test Gets CE Mark

NEW YORK – Molecular diagnostic firm PathoFinder announced Wednesday its SARS-CoV-2 detection kit has obtained the CE mark, allowing it to be marketed in the European Union and other countries recognizing the CE mark. 

The RealAccurate Quadruplex Corona-plus PCR kit detects SARS-CoV-2 from nasopharyngeal and oropharyngeal swabs within two hours. The test also detects Middle East Respiratory Syndrome.

The Maastricht, Netherlands-based company said it expects to be able to deliver "several thousands" of SARS-CoV-2 tests in the coming weeks.